On Point On Point

A ‘Female Viagra’ And Female Sexuality47:01

Play

A little pink pill to lift female sex drive gets a green light. The so-called ‘Viagra for Women.’ We’ll check it out.

In this file photo, a blackboard in Sprout Pharmaceuticals' Raleigh, N.C., headquarters makes an allusion to the male erectile dysfunction drug Viagra on Friday, Sept. 27, 2013. (AP)
In this file photo, a blackboard in Sprout Pharmaceuticals' Raleigh, N.C., headquarters makes an allusion to the male erectile dysfunction drug Viagra on Friday, Sept. 27, 2013. (AP)

A little pink pill called flibanserin got a green light last week from advisers to the FDA. Its purpose: to enhance sexual desire in women. The headline writers could not resist calling it “Viagra for women.” The same pill had been rejected twice before. At hearings it was called a “mediocre aphrodisiac with scary side effects.” But a big lobbying push demanded gender equity on the sex pill front – and finally got the panel’s recommendation. For “Viagra for women.” This hour On Point:  the little pink pill. Women, sex, side-effects and the making of desire.

Guests

Brigid Schulte, reporter covering social issues for the Washington Post. (@brigidschulte)

Dr. Lauren Streicher, associate professor of clinical obstetrics and gynecology at the Northwestern University's Feinberg School of Medicine. Author of "Sex Rx: Hormones, Health, and Your Best Sex Ever." (@drstreicher)

Leonore Tiefer, clinical associate professor of psychiatry at the New York University School of Medicine. Founder of the New View Campaign. (@ltiefer)

Terry O'Neill, president of the National Organization of Women. (@terryoneill)

From Tom’s Reading List

Washington Post: FDA advisory panel recommends approval of ‘female Viagra’ — "The first-ever 'female Viagra' came one step closer to coming to market,  as a key advisory committee to the Food and Drug Administration voted Thursday afternoon to recommend that the FDA approve the drug with conditions. The committee voted 18-6 to recommend that the FDA approve flibanserin, a drug designed to boost the low sexual desire of otherwise healthy women."

Vox: An FDA panel just backed the "female Viagra." Critics say it's a mistake. — "At the advisory committee meeting, the FDA gave a scientific presentation against the drug, arguing that it only resulted in eight more sexually satisfying events per year (when compared with a placebo) and that side effects were common. But the room was also filled with emotional testimony by women who feel they would greatly benefit from the medication. Sprout claims nearly one-tenth of premenopausal women suffer hypoactive sexual desire disorder.

Slate: How to Handle FDA Rejection — "Pharmaceutical companies have long been trying, and failing, to develop a pill to treat female sexual dysfunction. According to a study cited on Sprout’s website, '43% of women experienced some type of sexual dysfunction compared to 31% of men.' And the most common complaint from these women is low sexual desire. But, according to several medical experts I contacted for this story, the very idea that women can be cured from low sexual desire with a pill was created years ago by the drug industry. Flibanserin, they argue, is far from a cure-all.

+Join the Discussion
Please help keep our community civil. All comments must follow the WBUR Community rules.
Share

Support the news

Next Up

Where to now?

More On Point or Explore Audio.